James F. Howard

University of North Carolina at Chapel Hill

Also affiliated with University of North Carolina Health Care

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.5Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

BMJ Open(2020)10.1136/bmjopen-2020-037909

Top 23%

0.879DataRank

Top 23%20 citations

Richard J. Barohn, Emanuela Bartoccion, Michael Benatar, Derrick Blackmore, Vinay Chaudhry +35 more

Papers

Driven by 30 papers — median percentile 73. Top paper: “Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study”.

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

The Lancet Neurology(2023)10.1016/s1474-4422(23)00194-1

N/A

5.4DataRank · unranked

260 citations

Michael Benatar, Metin Kurtoğlu, Miloš D. Miljković, Nizar Chahin, Gregory Sahagian +37 more

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Neurology(2020)10.1212/wnl.0000000000011207

N/A

2.8DataRank · unranked

79 citations

Gil I. Wolfe, Srikanth Muppidi, Heinz Wiendl, Kenji P. Fujita, Fanny O’Brien +94 more

Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study

Therapeutic Advances in Neurological Disorders(2024)10.1177/17562864241243186

N/A

0.992DataRank · unranked

38 citations

Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma +23 more

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

BMJ Open(2020)10.1136/bmjopen-2020-037909

Top 23%

0.879DataRank

Top 23%20 citations

Richard J. Barohn, Emanuela Bartoccion, Michael Benatar, Derrick Blackmore, Vinay Chaudhry +35 more

Racial and Ethnic Differences in Timing of Diagnosis and Clinical Services Received in Duchenne Muscular Dystrophy

Neuroepidemiology(2023)10.1159/000528962

Top 30%

0.653DataRank

Top 30%16 citations

Yanan Zhang, Suzanne McDermott, Yinding Wang, Bo Cai, Kristin M. Conway +7 more

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

Annals of Clinical and Translational Neurology(2025)10.1002/acn3.70167

N/A

0.453DataRank · unranked

14 citations

Gregory Sahagian, Marc H. Feinberg, Charles A. Stewart, Christopher M. Jewell, Metin Kurtoğlu +6 more

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study

Therapeutic Advances in Neurological Disorders(2025)10.1177/17562864251347283

N/A

0.344DataRank · unranked

6 citations

Urvi Desai, Raghav Govindarajan, Min Kyun Kang, Shaida Khan, Bhupendra Khatri +11 more

First analysis of the Myasthenia Gravis SPOTLIGHT Registry: outcomes with eculizumab and ravulizumab

Journal of the Neurological Sciences(2025)10.1016/j.jns.2025.123628

N/A

0.312DataRank · unranked

7 citations

Dubravka Dodig, Lida Zeinali, Samir Macwan, Ashley Yegin, Michael Pulley +3 more

Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2108672119

N/A

0DataRank · unranked

133 citations

Sara Sáez-Atiénzar, Natalie A. Murphy, Adriano Chiò, Cornelis Blauwendraat, Ricardo H. Roda +48 more

Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2114406119

N/A

0DataRank · unranked

41 citations

Lily Guo, Xihui Yin, Ethan C. McCarthy, Mandy I. Cheng, Aline T. Hoang +12 more

Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network

Neuromuscular Disorders(2022)10.1016/j.nmd.2022.04.008

N/A

0DataRank · unranked

12 citations

Yinding Wang, Bo Cai, Kristin M. Conway, Nicholas E. Johnson, Shree Pandya +6 more

Role Attainment in Emerging Adulthood: Subjective Evaluation by Male Adolescents and Adults with Duchenne and Becker Muscular Dystrophy

Journal of Neuromuscular Diseases(2022)10.3233/jnd-210709

N/A

0DataRank · unranked

7 citations

T. Barbara, Neil M. Khosla, Pangaja Paramsothy, Stephen W. Erickson, Molly M. Lamb +7 more

Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials

Neurology(2023)10.1212/wnl.0000000000207278

N/A

0DataRank · unranked

27 citations

Michael Benatar, Volkan Granit, Ali A. Habib, James F. Howard, Carolina Barnett‐Tapia +7 more

Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence

Neuropsychiatric Disease and Treatment(2023)10.2147/ndt.s374694

N/A

0DataRank · unranked

23 citations

Heinz Wiendl, Masahisa Katsuno, Stephen Reddel, James F. Howard, Tuan Vu

Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis

Annals of Clinical and Translational Neurology(2023)10.1002/acn3.51761

N/A

0DataRank · unranked

22 citations

Minh Pham, Tabitha Karatz, Sangwook Oh, Aimee Payne, Richard J. Nowak +5 more

Twelve-Month Follow-Up of Patients With Generalized Myasthenia Gravis Receiving BCMA-Directed mRNA Cell Therapy

medRxiv(2024)10.1101/2024.01.03.24300770

N/A

0DataRank · unranked

15 citations

Gregory Sahagian, Marc H. Feinberg, Charles A. Stewart, Christopher M. Jewell, Metin Kurtoğlu +5 more

Long-term Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement Inhibitor, in Adults With Anti-acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-label Extension

Neurology(2024)10.1212/01.wnl.0001051364.68802.aa

N/A

0DataRank · unranked

0 citations

Renato Mantegazza, Djillali Annane, Masahisa Katsuno, Andreas Meisel, Michael Nicolle +5 more

In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al.

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102918

N/A

0DataRank · unranked

0 citations

Susan Manzi, Miloš D. Miljković, Tuan Vu, Tahseen Mozaffar, James F. Howard

In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al.

UNC Libraries(2024)10.17615/4bda-ea57

N/A

0DataRank · unranked

0 citations

Tuan Vu, Miloš D. Miljković, Susan Manzi, Tahseen Mozaffar, James F. Howard

Neuromuscular junction and the complement system

International review of neurobiology(2025)10.1016/bs.irn.2025.04.031

N/A

0DataRank · unranked

3 citations

James F. Howard, Saiju Jacob

Serum fibrinogen is not elevated in patients with myasthenia gravis

Scientific Reports(2025)10.1038/s41598-025-97599-8

N/A

0DataRank · unranked

3 citations

Sean M. Lee, Vern C. Juel, Yingkai Li, Karli F. Gilbert, Jiaxin Chen +11 more

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

The Lancet Neurology(2020)10.1016/s1474-4422(20)30413-0

N/A

0DataRank · unranked

121 citations

Jeffrey T. Guptill, Saiju Jacob, Yingkai Li, Maria Elena Farrugia, Amanda C. Guidon +40 more

Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis

Maryland Shared Open Access Repository (USMAI Consortium)(2025)10.13016/m2o2sh-xuyr

N/A

0DataRank · unranked

0 citations

Gregory Sahagian, Marc H. Feinberg, C. Andrew Stewart, Christopher M. Jewell, Metin Kurtoğlu +6 more

Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study

Muscle & Nerve(2020)10.1002/mus.26985

N/A

0DataRank · unranked

89 citations

Brandy Quarles, Jin‐Xiu Pan, Yu Zheng, James F. Howard, Andrea M. Corse +22 more

Complement Inhibitor Therapy for Myasthenia Gravis

Frontiers in Immunology(2020)10.3389/fimmu.2020.00917

N/A

0DataRank · unranked

74 citations

Henry J. Kaminski, James F. Howard, Khaled Albazli

Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis

Journal of Neuroimmunology(2020)10.1016/j.jneuroim.2020.577279

N/A

0DataRank · unranked

26 citations

Jeffrey T. Guptill, Melissa A. Russo, James F. Howard, Janice M. Massey, Vern C. Juel +7 more

Divergent Effects of T Cell Costimulation and Inflammatory Cytokine Production on Autoimmune Peripheral Neuropathy Provoked by Aire Deficiency

UNC Libraries(2020)10.17615/47km-w720

N/A

0DataRank · unranked

0 citations

Colin Jamal Smith, Xiaopei Lily Zeng, James F. Howard, Anil Nagavalli, Maureen A. Su

Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis

UNC Libraries(2020)10.17615/geds-zy27

N/A

0DataRank · unranked

0 citations

Tim Buchanan, Manisha Chopra, John S. Yi, Bryan Smith, Ehsanollah Esfandiari +7 more

Cellular changes in eculizumab early responders with generalized myasthenia gravis

Clinical Immunology(2021)10.1016/j.clim.2021.108830

N/A

0DataRank · unranked

10 citations

John S. Yi, James F. Howard, Manisha Chopra, Melissa A. Russo, Jeffrey T. Guptill +1 more

Health related quality of life in young, steroid-naïve boys with Duchenne muscular dystrophy

Neuromuscular Disorders(2021)10.1016/j.nmd.2021.06.001

N/A

0DataRank · unranked

8 citations

Elaine McColl, Michael McDermott, William B. Martens, Michela Guglieri, Robert C. Griggs +42 more

James F. Howard

Indexed papers

Top data-sharing exemplar

Papers